trial

tDCS and Executive Function Training for Schizophrenia

NCTId NCT05389345
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Withdrawn
Enrollment 0 (actual)
Sponsored by University of Toronto
Primary completion 2023-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2021-05-01
Primary completion
2023-12-31
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
transcranial direct current stimulationExecutive Function Training

Sponsors

University of TorontoLead Sponsor
Ontario Shores Centre for Mental Health SciencesCollaborator

Investigators

1
Michael W Best, PhDPrincipal Investigator

Sites

1 total
Whitby, Canada

Facts & assertions

4 sourced
Enrollment
0
Phase
NA
Primary Completion Date
2023-12-31
Status
WITHDRAWN
relationships
The graph out of here
drug
transcranial direct current stimulation
drug
Executive Function Training
drug
lead_sponsor
University of Toronto
company
collaborator
Ontario Shores Centre for Mental Health Sciences
company
indication
Schizophrenia
indication
Schizophrenia
indication
Schizophrenia and Related Disorders
indication
investigator
Michael W Best, PhD
person